Lataa...
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss
BACKGROUND: Hirudin is a potent thrombin inhibitor but its antithrombotic properties are offset by bleeding side-effects. Because hirudin’s N-terminus must engage thrombin’s active site for effective inhibition, fusing a cleavable peptide at this site may improve hirudin’s risk/benefit ratio as a th...
Tallennettuna:
| Julkaisussa: | BMC Biotechnol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5887181/ https://ncbi.nlm.nih.gov/pubmed/29621998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12896-018-0431-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|